BloggingStocks has a new home! Daily Finance.

Click here to visit the new home of BloggingStocks!

Hot on DailyFinance:

See More Stories

Option Update: Cardiome Pharma July volatility elevated at 195 into data release

Posted Jul 8th 2008 11:00AM by Paul FosterPaul Foster RSS Feed
Filed under: Options


Cardiome Pharma (NASDAQ: CRME) closed at $8.66 Monday.

Phase 2b data is expected soon for a oral formulation of Kynapid (vernakalant), a drug to restore normal heart rhythm in patients with arterial fibrillation.

CRME July option implied volatility of 195 is above its 26-week average of 131 according to Track Data, suggesting larger price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Tags: Cardiome Pharma, CardiomePharma, crme, option implied volatility, OptionImpliedVolatility

Print this
Symbol Lookup
IndexesChangePrice
DJIA+80.4512,881.68
NASDAQ+26.732,930.61
S&P 500+9.771,352.41

Last updated: February 13, 2012: 02:43 PM

Hot Stocks

General Electric

19.055+0.18(+0.95)

Alcoa

10.33+0.04(+0.39)

Apple Inc

500.18+6.76(+1.37)

Google Inc 'A'

613.20+7.29(+1.20)

Bank of America

8.285+0.215(+2.66)

Wal-Mart Stores

61.87-0.03(-0.05)

Exxon Mobil Corp

84.51+0.71(+0.85)

Ford

12.565+0.125(+1.00)

Citigroup

33.18+0.255(+0.77)

IBM

192.71+0.29(+0.15)

Yahoo

16.145+0.005(+0.03)

Starbucks

49.16+0.34(+0.70)

Microsoft

30.65+0.155(+0.51)

Home Depot

46.025+0.695(+1.53)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

  • My Portfolio
  • Create a New Portfolio

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1329162209355 ms.